147 related articles for article (PubMed ID: 12541044)
21. Detection and prognostic impact of disseminated tumor cells in pancreatic carcinoma.
Vogel I; Kalthoff H; Henne-Bruns D; Kremer B
Pancreatology; 2002; 2(2):79-88. PubMed ID: 12123098
[TBL] [Abstract][Full Text] [Related]
22. Comparison of metastatic behavior of parental and metastatic pancreatic cancer cell lines in Syrian golden hamsters.
Morioka CY; Saito S; Machado MC; Ohzawa K; Yamago GI; Bacchella T; Watanabe A
In Vivo; 2004; 18(1):63-6. PubMed ID: 15011753
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in the detection of bone marrow micrometastases: A promising area for research or just another false hope? A review of the literature.
Athanassiadou P; Grapsa D
Cancer Metastasis Rev; 2006 Dec; 25(4):507-19. PubMed ID: 17160555
[TBL] [Abstract][Full Text] [Related]
24. Influence of subclinical tumor spreading on survival after curative surgery for colorectal cancer.
Steinert R; Hantschick M; Vieth M; Gastinger I; Kühnel F; Lippert H; Reymond MA
Arch Surg; 2008 Feb; 143(2):122-8. PubMed ID: 18283136
[TBL] [Abstract][Full Text] [Related]
25. Hepatic disseminated tumor cells in colorectal cancer UICC stage 4 patients: prognostic implications.
Schimanski CC; Linnemann U; Galle PR; Arbogast R; Berger MR
Int J Oncol; 2003 Sep; 23(3):791-6. PubMed ID: 12888919
[TBL] [Abstract][Full Text] [Related]
26. [The role of vascular reconstructions in the surgery of tumors of the hepatopancreatobiliary zone].
Granov DA; Maĭstrenko DN; Zherebtsov FK; Polysalov VN; Pirtskhalava TL; Pavlovskiĭ AV; Rutkin IO; Borovik VV
Vestn Khir Im I I Grek; 2008; 167(5):43-7. PubMed ID: 19069821
[TBL] [Abstract][Full Text] [Related]
27. The efficacy of diffusion-weighted imaging for the detection of colorectal cancer.
Shinya S; Sasaki T; Nakagawa Y; Guiquing Z; Yamamoto F; Yamashita Y
Hepatogastroenterology; 2009; 56(89):128-32. PubMed ID: 19453043
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H
Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245
[TBL] [Abstract][Full Text] [Related]
29. Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?
Lang JE; Hall CS; Singh B; Lucci A
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1463-72. PubMed ID: 17944570
[TBL] [Abstract][Full Text] [Related]
30. Incidence and prognostic significance of occult tumor cells in lymph nodes from patients with stage IIA colorectal carcinoma.
Messerini L; Cianchi F; Cortesini C; Comin CE
Hum Pathol; 2006 Oct; 37(10):1259-67. PubMed ID: 16949928
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
[TBL] [Abstract][Full Text] [Related]
32. Clinical evaluation of a panel of mRNA markers in the detection of disseminated tumor cells in patients with operable breast cancer.
Varangot M; Barrios E; Sóñora C; Aizen B; Pressa C; Estrugo R; Lavigna R; Musé I; Osinaga E; Berois N
Oncol Rep; 2005 Aug; 14(2):537-45. PubMed ID: 16012742
[TBL] [Abstract][Full Text] [Related]
33. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
Béhé M; Behr TM
Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
[TBL] [Abstract][Full Text] [Related]
34. Modeling growth kinetics and statistical distribution of oligometastases.
Withers HR; Lee SP
Semin Radiat Oncol; 2006 Apr; 16(2):111-9. PubMed ID: 16564446
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.
Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH
Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614
[TBL] [Abstract][Full Text] [Related]
36. The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer.
Sierzega M; Popiela T; Kulig J; Nowak K
Pancreas; 2006 Oct; 33(3):240-5. PubMed ID: 17003644
[TBL] [Abstract][Full Text] [Related]
37. BM micrometastases and circulating tumor cells in breast cancer patients: where have we been, where are we now and where does the future lie?
Müller V; Pantel K
Cytotherapy; 2005; 7(6):478-82. PubMed ID: 16306009
[TBL] [Abstract][Full Text] [Related]
38. Immunocytochemical detection of occult tumor cells in the bone marrow: prognostic impact on early stages of lung cancer.
Nosotti M; Tosi D; Palleschi A; Rosso L; Mendogni P; Santambrogio L
Eur Surg Res; 2008; 41(3):267-71. PubMed ID: 18594145
[TBL] [Abstract][Full Text] [Related]
39. Detection of occult metastasis in lymph nodes from colorectal cancer patients: a multiple-marker reverse transcriptase-polymerase chain reaction study.
Chen G; McIver CM; Texler M; Lloyd JM; Rieger N; Hewett PJ; Sen Wan D; Hardingham JE
Dis Colon Rectum; 2004 May; 47(5):679-86. PubMed ID: 15037935
[TBL] [Abstract][Full Text] [Related]
40. Current status in human breast cancer micrometastasis.
Alix-Panabières C; Müller V; Pantel K
Curr Opin Oncol; 2007 Nov; 19(6):558-63. PubMed ID: 17906452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
